A KCR1 variant implicated in susceptibility to the long QT syndrome

►A variant of KCR1 (E33D) was identified from a patient with VF and QT prolongation. ►The E33D variant does not protect KCNH2 from the effects of channel blockers. ►The E33D variant leads to a loss of enzymatic a-glycosyltransferase function.